Carillon Tower Advisers is Optimistic on MarineMax (HZO), Here’s Why
Carillon Tower Advisers, an investment management firm, published its “Carillon Eagle Small Cap Growth Fund” first quarter 2021 investor letter – a copy of which can be downloaded here. Small-cap stocks advanced once again in the first quarter of 2021. However, there was a rather considerable disparity among the two style indexes, as the Russell 2000® Growth Index (up 4.87%) significantly lagged its Russell 2000® Value Index counterpart (up 21.16%). You can view the fund’s top 5 holdings to have a peek at their top bets for 2021.
Carillon Eagle Small Cap Growth Fund, in their Q1 2021 investor letter, mentioned MarineMax, Inc. (NYSE: HZO), and shared their insights on the company. MarineMax, Inc. is a Clearwater, Florida-based recreational boat and yacht retailer that currently has a $1.3 billion market capitalization. Since the beginning of the year, HZO delivered a 78.08% return, extending its 12-mon
Is Entegris Inc. (ENTG) A Smart Long-Term Buy?
Carillon Tower Advisers, an investment management firm, published its “Carillon Eagle Small Cap Growth Fund” first quarter 2021 investor letter – a copy of which can be downloaded here. Small-cap stocks advanced once again in the first quarter of 2021. However, there was a rather considerable disparity among the two style indexes, as the Russell 2000® Growth Index (up 4.87%) significantly lagged its Russell 2000® Value Index counterpart (up 21.16%). You can view the fund’s top 5 holdings to have a peek at their top bets for 2021.
Carillon Eagle Small Cap Growth Fund, in their Q1 2021 investor letter, mentioned Entegris, Inc. (NASDAQ: ENTG), and shared their insights on the company. Entegris, Inc. is a Billerica, Massachusetts-based manufacturing company that currently has a $14.7 billion market capitalization. Since the beginning of the year, ENTG delivered a 13.31% return, extending its 12-month gains to 108.76%. As of May
Is Amicus Therapeutics Inc. (FOLD) A Smart Long-Term Buy?
Carillon Tower Advisers, an investment management firm, published its “Carillon Eagle Small Cap Growth Fund” first quarter 2021 investor letter – a copy of which can be downloaded here. Small-cap stocks advanced once again in the first quarter of 2021. However, there was a rather considerable disparity among the two style indexes, as the Russell 2000® Growth Index (up 4.87%) significantly lagged its Russell 2000® Value Index counterpart (up 21.16%). You can view the fund’s top 5 holdings to have a peek at their top bets for 2021.
Carillon Eagle Small Cap Growth Fund, in their Q1 2021 investor letter, mentioned Amicus Therapeutics, Inc. (NASDAQ: FOLD), and shared their insights on the company. Amicus Therapeutics, Inc. is a Philadelphia, Pennsylvania-based biopharmaceutical company that currently has a $2.5 billion market capitalization. Since the beginning of the year, FOLD delivered a -57.97% return, while its 12